Lees Pharmaceutical Holdings Performance
| LPCUFDelisted Stock | USD 0.0001 0.00 0.00% |
The company secures a Beta (Market Risk) of 2.48, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Lees Pharmaceutical will likely underperform. Lees Pharmaceutical right now secures a risk of 0.0%. Please verify Lees Pharmaceutical Holdings mean deviation, information ratio, as well as the relationship between the Information Ratio and kurtosis , to decide if Lees Pharmaceutical Holdings will be following its current price movements.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Lees Pharmaceutical Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Lees Pharmaceutical is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 375.2 M | |
| Total Cashflows From Investing Activities | -370.3 M |
Lees |
Lees Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 0.01 in Lees Pharmaceutical Holdings on September 3, 2024 and sell it today you would earn a total of 0.00 from holding Lees Pharmaceutical Holdings or generate 0.0% return on investment over 90 days. Lees Pharmaceutical Holdings is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Lees, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Lees Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lees Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Lees Pharmaceutical Holdings, and traders can use it to determine the average amount a Lees Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| LPCUF |
Based on monthly moving average Lees Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lees Pharmaceutical by adding Lees Pharmaceutical to a well-diversified portfolio.
Lees Pharmaceutical Fundamentals Growth
Lees Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Lees Pharmaceutical, and Lees Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Lees Pink Sheet performance.
| Return On Equity | -0.0531 | |||
| Return On Asset | 0.0591 | |||
| Profit Margin | (0.09) % | |||
| Operating Margin | (1.58) % | |||
| Current Valuation | 123.64 M | |||
| Shares Outstanding | 588.84 M | |||
| Price To Book | 0.0002 X | |||
| Price To Sales | 0.10 X | |||
| Revenue | 1.27 B | |||
| EBITDA | 1.98 B | |||
| Cash And Equivalents | 368.05 M | |||
| Cash Per Share | 0.62 X | |||
| Total Debt | 84.09 M | |||
| Debt To Equity | 0.11 % | |||
| Book Value Per Share | 3.64 X | |||
| Cash Flow From Operations | 210.68 M | |||
| Total Asset | 3.64 B | |||
About Lees Pharmaceutical Performance
By analyzing Lees Pharmaceutical's fundamental ratios, stakeholders can gain valuable insights into Lees Pharmaceutical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Lees Pharmaceutical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Lees Pharmaceutical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Lees Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products primarily in the Peoples Republic of China. The company was founded in 1994 and is headquartered in Sha Tin, Hong Kong. Lees Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1182 people.Things to note about Lees Pharmaceutical performance evaluation
Checking the ongoing alerts about Lees Pharmaceutical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Lees Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Lees Pharmaceutical is not yet fully synchronised with the market data | |
| Lees Pharmaceutical has some characteristics of a very speculative penny stock | |
| Lees Pharmaceutical has a very high chance of going through financial distress in the upcoming years | |
| About 64.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Lees Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Lees Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining Lees Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Lees Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Lees Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Lees Pharmaceutical's pink sheet. These opinions can provide insight into Lees Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Lees Pink Sheet
If you are still planning to invest in Lees Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Lees Pharmaceutical's history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |